Xeris Biopharma Holdings Inc (XERS)

Xeris Biopharma Holdings Inc (XERS) 재무 분석

손익 계산서

분기별

*모든 숫자는 백만 단위입니다.

기간 종료일	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
기간	3개월	3개월	3개월	3개월	3개월
Revenues	8.45% 40.64	44.39	48.32	38.01	33.20
Operating Expenses	1.20% 54.88	54.23	53.23	53.99	46.47
Interest Income/Expense	0.20% 7.032	7.018	6.847	6.528	6.216
Benefits Costs and Expenses	100.00% -	227.42	-	-	-
Costs And Expenses	25.56% 54.88	73.72	53.23	53.99	46.47
Operating Income/Loss	44.75% -14.24	-9.841	-4.913	-15.98	-13.28
Income/Loss From Continuing Operations Before Tax	122.20% 40.64	-183.03	48.32	-19.84	-16.83
Income Tax Expense/Benefit, Deferred	0.307	-	-	-	-
Income Tax Expense/Benefit	230.08% 0.307	-0.236	-0.338	-0.675	-
Income/Loss From Continuing Operations After Tax	41.75% -18.98	-13.39	-12.19	-19.84	-16.83
Net Income/Loss	41.75% -18.98	-13.39	-12.19	-19.84	-16.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	92,554% 140.51	0.1517	138.06	137.34	137.14
Diluted Average Shares	92,554% 140.51	0.1517	138.06	137.34	137.14
Basic Earnings Per Share	55.56% -0.14	-0.09	-0.09	-0.14	-0.12
Diluted Earnings Per Share	55.56% -0.14	-0.09	-0.09	-0.14	-0.12
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-